A candidate tumor suppressor gene, FHIT, was indicated at chromosome 3p14.2 spanning the FRA3B common fragile site. Abnormalities in structure and expression of the FHIT gene have been detected in a considerable fraction of lung tumors of small and non-small cell types. There are several reports on the correlations between abnormalities of the FHIT gene and clinicopathological features in lung cancer. For research use only, not for use in diagnostic procedures.
- application:
- WB, IHC
- Catalog number:
- 18163-S
- Datasheet:
- formulation:
- Lyophilized product from 1% BSA in PBS containing 0.05% NaN3
- immunogen:
- Synthetic peptide for C-terminal of Human FHIT
- MSDS:
- notes:
- For research use only, not for use in diagnostic procedures.
The datasheet for this product (see above) is intended to serve as an example only. Please refer to the datasheet provided with the antibody for precise details. - Other names:
- Please see datasheet
- Protocol:
- purification:
- Affinity Purified with synthetic peptide
- size:
- 10 µg
- specificity:
- Please see datasheet
- storage:
- Lyophilized product, 5 years at 2 - 8 °C; Solution, 2 years at -20 °C.
- Species:
- Human
- Host:
- Rabbit
